Stoke Therapeutics Inc (STOK)
11.86
-0.55
(-4.43%)
USD |
NASDAQ |
Apr 29, 16:00
11.20
-0.66
(-5.56%)
After-Hours: 06:22
Stoke Therapeutics Shareholders Equity (Quarterly): 159.56M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 159.56M |
| September 30, 2023 | 173.00M |
| June 30, 2023 | 190.20M |
| March 31, 2023 | 213.82M |
| December 31, 2022 | 184.85M |
| September 30, 2022 | 204.14M |
| June 30, 2022 | 224.32M |
| March 31, 2022 | 239.98M |
| December 31, 2021 | 217.78M |
| September 30, 2021 | 237.51M |
| June 30, 2021 | 255.07M |
| Date | Value |
|---|---|
| March 31, 2021 | 272.46M |
| December 31, 2020 | 286.08M |
| September 30, 2020 | 192.54M |
| June 30, 2020 | 203.40M |
| March 31, 2020 | 214.34M |
| December 31, 2019 | 224.43M |
| September 30, 2019 | 233.68M |
| June 30, 2019 | 241.54M |
| March 31, 2019 | 99.58M |
| December 31, 2018 | 105.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
159.56M
Minimum
Dec 2023
286.08M
Maximum
Dec 2020
219.41M
Average
217.78M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 9.137M |
| iBio Inc | 9.197M |
| Actinium Pharmaceuticals Inc | 36.38M |
| Lixte Biotechnology Holdings Inc | 3.995M |
| Fate Therapeutics Inc | 368.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 228.34M |
| Total Liabilities (Quarterly) | 68.78M |
| Current Ratio | 6.987 |